messag constel report strong start beat expect
driven primarili record-high gross margin benefit like sustain
throughout year remain among bearish sell-sid analyst stock
given continu deceler beer busi signific risk associ
canopi invest lower ep estim
 due entir lower canopi
earn price target remain unchang
report consolid organ sale growth vs gs adjust ep
ahead includ constel share canopi earn
subtract beer deplet gener ahead investor
expect base convers especi given unfavor weather major
market like california texa thank mostli acceler modelo drive
beat quarter vs model stronger beer price vs gs
except strong gross margin exceed estim go
quarter overestim potenti neg impact price margin due
increas promot activ corona extra can despit better
neg thesi remain unchang reiter neutral given growth beer
portfolio deceler structur difficult grow long-term key mexican
import brand contractu limit us specul invest
canopi make stock significantli riskier view
ep estim assum canopi impact constel ep
higher guidanc due core busi manag rais ep guidanc
midpoint rang entir reflect
push pend divestitur select wine brand one quarter estim
addit quarter earn worth roughli ep off-set higher interest
due delay repay debt divestitur proce increas
core ep toward high end guidanc rang
think still flexibl fund profit upsid exampl
compani elimin strand cost wine divestitur faster illustr point
assum segment grow midpoint guidanc rang sale
oper incom corpor cost sale vs last year interest
expens guidanc model suggest ep closer
beer deceler progress continu see clear deceler beer
busi last year innov corona premier corona familiar continu
cannib extra modelo perform well expect continu
premier familiar lap respect launch last year dont expect
major contribut corona refresca fill gap evid concern
compani said beer deplet driven modelo double-digit
premier impli corona extra flat slightli manag maintain
sale oper incom growth guidanc beer model
sale growth oper incom growth given margin
could make us posit neg neg side see downsid
model compani continu discount corona rang especi abi get
aggress new strateg focu similarli price portfolio especi michelob
ultra ultra gold infus stella artoi long-term also see increment risk
canopi monster abl success develop cbd beverag leverag
strong exist monster brand posit side potenti sourc upsid could
come better perform refresca sustain growth modelo
expect final canopi would clear beneficiari cbd get approv faster
us expect although canada push cannabi edibl drinkabl
approv octob decemb
page analyst certif import disclosur
expect constel beer portfolio growth deceler nearli
model beer segment organ growth
estim consid higher volum corona refresca expect reach
retail sale acv howev growth estim reflect
lack innov assum refresca wont signific factor futur growth beer
figur growth estim reflect expect continu beer portfolio
deceler
brand basi expect corona growth level remain rel flat
modelo hand continu strong momentum expect
primari growth driver next year
consist previou expect think compani slowli phase corona
favor premier given consum avers light label
page analyst certif import disclosur
sale growth project retail sale growth total beer portfoliotot retail portfoliohistor cagrproject compound-annual-growth-rate beverag
figur calendar year basi beer portfolio estim inform
brand estim assum corona stabil flat modelo grow
increment boost premier familiar
recent nielsen trend appar corona premier cannib core corona
franchis corona extra corona light without increment gain combin
strateg think introduct premier misstep manag part
compani decid sell premier premium price extra
dynam would benefici algorithm howev given list price
addit premier serv financi purpos portfolio
corona extra corona light share mexican import last
respect period year ago importantli
share corona franchis includ extra premier familiar extens
mexican import fallen period year ago
figur corona franchis lose share despit success premier
corona light continu weaken declin latest period corona
extra stabil return slight growth longer growth engin
use
page analyst certif import disclosur
calend year beer cy retail valu share retail valu share mexican import segmentextrapremierfamiliar beverag
figur corona extra stabil corona light continu declin
page analyst certif import disclosur
expens approach particip cannabi
total constel invest canopi growth canadian-bas publicli trade
cannabi compani total ownership object invest view
captur first-mov advantag bring cannabi beverag product canadian
market ultim goal constel leverag experi eventu launch
us marijuana legal feder level
bigger stronger competitor enter mix
decemb ab inbev abi enter strateg partnership tilray research
non-alcohol beverag contain cbd also recal august molson coor
hydropothecari corpor enter joint ventur pursu opportun develop non-
alcohol cannabis-infus beverag canadian market follow legal
canopi current primarili medicin constel doesnt expertis
simpli provid cash contrast novarti announc decemb global suppli
distribut agreement medic marijuana tilray novarti bring signific
expertis capabl well global commerci network addit altria
us tobacco compani announc decemb invest crono group
canadian cannabi compani stake option increas
next year add competit marijuana vape smoke space
potenti threat monster
recent sharehold meet june monster manag said cannabis-bas
innov tabl assum us feder legal think monster brand would
ideal suit extend cannabi potenti cbd formul
alreadi work
wherea canopi build brand scratch someth constel doesnt
experi monster strong exist brand could leverag quickli
enter space gain consum attent
longer timelin investor expect
cagni lunch attend first canopi growth ceo bruce linton decemb
later michael gorenstein ceo crono june gather insight
marijuana industri regul timelin key approv feder would
need regul fda linton say would posit categori
could add one two year process base experi fda approv
legal commerci hemp thank decemb us pave
way expans first cbd consum product yet see addit
guidanc fda matter
addit recal recreat edibl drinkabl cannabi product expect
becom nation legal canada octob howev june canada
medic regul canada said sale wont begin late decemb add credenc
notion medicin recreat marijuana busi could eventu signific
canada us think day still year away due complex
associ least fda approv process requir
page analyst certif import disclosur
recal canopi growth constel current own announc april
intent acquir acreag hold pend feder legal cannabi unit
state concurr announc constel canopi amend
preexist investor right agreement pertin expiri date
warrant extend constel ownership canopi longer exceed
part revis term constel tranch tranch warrant
canopi previous expir expir tranch extend
year tranch split two new tranch tranch tranch
 expir extend year
see posit reduc risk associ constel high
debt burden exercis warrant origin stipul provid
flexibl de-lever prior exercis amend warrant increas
sharehold return share buyback dividend afford constel
time exercis warrant better assess viabil canopi
busi model canada potenti us eventu likelihood us
canopi impact constel earn
use updat consensu estim canopi growth earn see invest
canopi becom progress less drag constel ep throughout
accret ep begin
figur see canopi earn becom accret constel ep
start
page analyst certif import disclosur
ep canopi earn impact ep beverag
wine divestitur long-term posit
compani announc april sale select wine brand gallo
expect close second half compani updat guidanc
estim transact close
market reward divestitur lower price-point wine brand essenti
fix problem constel least past year struggl wine
spirit segment perform estim sale brand add roughli pt
segment growth bp segment oper margin result expect
consolid oper margin expand nearli
compani elimin strand cost henc ep growth
long-term continu think limit synergi wine
spirit beer
page analyst certif import disclosur
valuat risk
price target base blend multipl forward earn estim
previous price-to-earnings ev/ebitda rel histori think
stock merit discount price-to-earnings trade past given
higher level risk follow invest canopi growth pronounc
deceler beer segment immedi point inflect
risk upsid given valuat neutral rate
better expect perform new innov includ corona premier
corona familiar littl cannib core corona busi
continu expans corona modelo acv beyond think variou
packag format achiev
feder legal marijuana us success expans new
innov canopi growth
risk downsid given valuat neutral rate
corona premier familiar continu cannib corona franchis
rapid pace expect corona extra declin worsen
canopi invest provid higher earlier expect return rapid
legal recreat marijuana us
corona refresca fail add increment growth overal corona franchis
page analyst certif import disclosur
